Actively Recruiting
Intraductal Radiofrequency Thermoablation and Radiotherapy Combined Treatment for Extrahepatic Cholangiocarcinoma
Led by National Cancer Center, Korea · Updated on 2025-06-19
53
Participants Needed
1
Research Sites
325 weeks
Total Duration
On this page
Sponsors
N
National Cancer Center, Korea
Lead Sponsor
B
Boston Scientific Corporation
Collaborating Sponsor
AI-Summary
What this Trial Is About
\[Study objectives\] To evaluate the efficacy and safety of the combined treatment of radiotherapy and endoscopic intraductal radiofrequency ablation in patients with locoregional extrahepatic cholangiocarcinoma.
CONDITIONS
Official Title
Intraductal Radiofrequency Thermoablation and Radiotherapy Combined Treatment for Extrahepatic Cholangiocarcinoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients 20 years of age or older who voluntarily agree to participate and sign informed consent
- Patients with cytopathologically diagnosed inoperable extrahepatic cholangiocarcinoma
You will not qualify if you...
- Patients who refuse to sign informed consent
- Patients with metastatic cancer (stage IV) or malignant ascites
- Patients with intrahepatic cholangiocarcinoma
- Patients unable to undergo endoscopic procedures as determined by the investigator
- Patients with a life expectancy of 3 months or less
- Patients with contraindications to ID-RFA such as pacemaker, pregnancy, or uncorrected bleeding tendency (PT INR > 1.5, platelets < 50,000/mm3)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Cancer Center, Korea
Goyang-si, Other, South Korea, 10408
Actively Recruiting
Research Team
S
Sang Myung Woo, M.D
CONTACT
J
Jung Won Chun, M.D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here